PF-06815345

DB14862InvestigationalSmall molecule

PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).

Chemical structure of PF-06815345
Formula / weight
C27H29ClFN9O4 · 598.04 g/mol (avg)
Code names
PF-06815345

Resolves to

Compound
UNII4H9X9HO87KCAS1900686-46-5
Structure
InChIKeyQTBYVAZRKWOIDU-FUHWJXTLSA-NSMILESCCOC(=O)O[C@@H](C)N1N=NN=C1C1=C(C=NN1C)C1=CC=C(C=C1F)C(=O)N([C@@H]1CCCNC1)C1=NC=CC=C1Cl

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of PF-06815345, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In